Chlorthalidone Tablets Recalled for Temperature Storage Deviations
Cardinal Healthcare is recalling Chlorthalidone Tablets, 25mg (Batch 2107329UM) distributed nationwide because products were exposed to temperatures outside the labeled storage conditions.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for a CGMP deviation involving temperature exposure outside labeled storage conditions. No illnesses, injuries, or adverse events have been reported. Per the rubric, precautionary recalls without reported harm and no Class I classification warrant a Moderate severity score.
Plain-English summary
Cardinal Healthcare is recalling Chlorthalidone Tablets, USP, 25mg (NDC: 43598-719-10, Batch 2107329UM) due to Current Good Manufacturing Practice (CGMP) deviations. The products were exposed to temperatures outside of the labeled storage conditions during manufacturing or distribution.
Chlorothalidone is a thiazide-like diuretic prescribed to treat high blood pressure and fluid retention. The recalled product was distributed nationwide.
Consumers in possession of the recalled product should consult with their pharmacist or healthcare provider about obtaining replacement medication. Do not use products from the affected batch.
The recalled product
- Product
- CHLORTHALIDONE (CHLORTHALIDONE)
- Brand
- CHLORTHALIDONE
- Manufacturer
- CARDINAL HEALTHCARE
- Category
- Drug — Thiazide Diuretic
- Hazard
- temperature-excursion
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Batch 2107329UM
UPCs (1)
- 0343598720012
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CHLORTHALIDONE
- HighChlorthalidone Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2025-06-18
- ModerateChlorthalidone Tablets Recalled for Foreign Matter Contamination
FDA (Drugs) · 2022-02-23
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27